These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

577 related items for PubMed ID: 28456008

  • 21. Functional Maturation of Induced Pluripotent Stem Cell Hepatocytes in Extracellular Matrix-A Comparative Analysis of Bioartificial Liver Microenvironments.
    Wang B, Jakus AE, Baptista PM, Soker S, Soto-Gutierrez A, Abecassis MM, Shah RN, Wertheim JA.
    Stem Cells Transl Med; 2016 Sep; 5(9):1257-67. PubMed ID: 27421950
    [Abstract] [Full Text] [Related]

  • 22. Homogeneous Differentiation of Functional Hepatocytes from Human Induced Pluripotent Stem Cells.
    Li R, Zhao Y, Yourick JJ, Sprando RL, Gao X.
    Methods Mol Biol; 2022 Sep; 2429():127-142. PubMed ID: 35507159
    [Abstract] [Full Text] [Related]

  • 23. Hepatocyte-like cells differentiated from human induced pluripotent stem cells: relevance to cellular therapies.
    Yu Y, Liu H, Ikeda Y, Amiot BP, Rinaldo P, Duncan SA, Nyberg SL.
    Stem Cell Res; 2012 Nov; 9(3):196-207. PubMed ID: 22885101
    [Abstract] [Full Text] [Related]

  • 24. Using Human Induced Pluripotent Stem Cell-derived Hepatocyte-like Cells for Drug Discovery.
    Liu JT, Lamprecht MP, Duncan SA.
    J Vis Exp; 2018 May 19; (135):. PubMed ID: 29863663
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Modeling of Hepatic Drug Metabolism and Responses in CYP2C19 Poor Metabolizer Using Genetically Manipulated Human iPS cells.
    Deguchi S, Yamashita T, Igai K, Harada K, Toba Y, Hirata K, Takayama K, Mizuguchi H.
    Drug Metab Dispos; 2019 Jun 19; 47(6):632-638. PubMed ID: 30962288
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Generation of hepatocyte-like cells from human induced pluripotent stem (iPS) cells by co-culturing embryoid body cells with liver non-parenchymal cell line TWNT-1.
    Javed MS, Yaqoob N, Iwamuro M, Kobayashi N, Fujiwara T.
    J Coll Physicians Surg Pak; 2014 Feb 19; 24(2):91-6. PubMed ID: 24491001
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Efficient Engraftment of Human Induced Pluripotent Stem Cell-Derived Hepatocyte-Like Cells in uPA/SCID Mice by Overexpression of FNK, a Bcl-xL Mutant Gene.
    Nagamoto Y, Takayama K, Tashiro K, Tateno C, Sakurai F, Tachibana M, Kawabata K, Ikeda K, Tanaka Y, Mizuguchi H.
    Cell Transplant; 2015 Feb 19; 24(6):1127-38. PubMed ID: 24806294
    [Abstract] [Full Text] [Related]

  • 32. Generation of expandable human pluripotent stem cell-derived hepatocyte-like liver organoids.
    Mun SJ, Ryu JS, Lee MO, Son YS, Oh SJ, Cho HS, Son MY, Kim DS, Kim SJ, Yoo HJ, Lee HJ, Kim J, Jung CR, Chung KS, Son MJ.
    J Hepatol; 2019 Nov 19; 71(5):970-985. PubMed ID: 31299272
    [Abstract] [Full Text] [Related]

  • 33. Generation of metabolically functioning hepatocytes from human pluripotent stem cells by FOXA2 and HNF1α transduction.
    Takayama K, Inamura M, Kawabata K, Sugawara M, Kikuchi K, Higuchi M, Nagamoto Y, Watanabe H, Tashiro K, Sakurai F, Hayakawa T, Furue MK, Mizuguchi H.
    J Hepatol; 2012 Sep 19; 57(3):628-36. PubMed ID: 22659344
    [Abstract] [Full Text] [Related]

  • 34. Regulation of Human Pluripotent Stem Cell-Derived Hepatic Cell Phenotype by Three-Dimensional Hydrogel Models.
    Toivonen S, Malinen MM, Küblbeck J, Petsalo A, Urtti A, Honkakoski P, Otonkoski T.
    Tissue Eng Part A; 2016 Jul 19; 22(13-14):971-84. PubMed ID: 27329070
    [Abstract] [Full Text] [Related]

  • 35. Calcitriol promotes the maturation of hepatocyte-like cells derived from human pluripotent stem cells.
    Yuan F, Wang N, Chen Y, Huang X, Yang Z, Xu Y, You K, Zhang J, Wang G, Zhuang Y, Pan T, Xiong Y, Yu X, Yang F, Li Y.
    J Steroid Biochem Mol Biol; 2021 Jul 19; 211():105881. PubMed ID: 33766737
    [Abstract] [Full Text] [Related]

  • 36. The role of epigenetic modifiers in extended cultures of functional hepatocyte-like cells derived from human neonatal mesenchymal stem cells.
    Cipriano M, Correia JC, Camões SP, Oliveira NG, Cruz P, Cruz H, Castro M, Ruas JL, Santos JM, Miranda JP.
    Arch Toxicol; 2017 Jun 19; 91(6):2469-2489. PubMed ID: 27909741
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Toxicological applications of human induced pluripotent stem cell-derived hepatocyte-like cells: an updated review.
    Gao X, Yourick JJ, Sprando RL.
    J Toxicol Sci; 2023 Jun 19; 48(8):441-456. PubMed ID: 37532578
    [Abstract] [Full Text] [Related]

  • 39. Improvements in Maturity and Stability of 3D iPSC-Derived Hepatocyte-like Cell Cultures.
    Suominen S, Hyypijev T, Venäläinen M, Yrjänäinen A, Vuorenpää H, Lehti-Polojärvi M, Räsänen M, Seppänen A, Hyttinen J, Miettinen S, Aalto-Setälä K, Viiri LE.
    Cells; 2023 Sep 27; 12(19):. PubMed ID: 37830581
    [Abstract] [Full Text] [Related]

  • 40. Identification of an FXR-modulated liver-intestine hybrid state in iPSC-derived hepatocyte-like cells.
    Nell P, Kattler K, Feuerborn D, Hellwig B, Rieck A, Salhab A, Lepikhov K, Gasparoni G, Thomitzek A, Belgasmi K, Blüthgen N, Morkel M, Küppers-Munther B, Godoy P, Hay DC, Cadenas C, Marchan R, Vartak N, Edlund K, Rahnenführer J, Walter J, Hengstler JG.
    J Hepatol; 2022 Nov 27; 77(5):1386-1398. PubMed ID: 35863491
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.